Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Non-Current Assets (2016 - 2022)

Edesa Biotech's Non-Current Assets history spans 10 years, with the latest figure at $2.4 million for Q2 2022.

  • For Q2 2022, Non-Current Assets fell 7.17% year-over-year to $2.4 million; the TTM value through Jun 2022 reached $9.7 million, down 6.67%, while the annual FY2021 figure was $2.5 million, 6.19% down from the prior year.
  • Non-Current Assets for Q2 2022 was $2.4 million at Edesa Biotech, down from $2.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.7 million in Q2 2020 and bottomed at $103929.0 in Q2 2019.
  • The 5-year median for Non-Current Assets is $2.4 million (2022), against an average of $1.7 million.
  • The largest annual shift saw Non-Current Assets tumbled 91.1% in 2019 before it skyrocketed 2499.8% in 2020.
  • A 5-year view of Non-Current Assets shows it stood at $1.0 million in 2018, then crashed by 74.73% to $262157.0 in 2019, then skyrocketed by 900.71% to $2.6 million in 2020, then dropped by 6.55% to $2.5 million in 2021, then decreased by 3.7% to $2.4 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Non-Current Assets are $2.4 million (Q2 2022), $2.4 million (Q1 2022), and $2.5 million (Q4 2021).